InterMune Inc (NASDAQ:ITMN) Investor Alert: Investigation of Takeover by Roche
An investigation on behalf of investors, who currently hold shares of InterMune Inc (NASDAQ:ITMN), was announced concerning whether the takeover of InterMune Inc by Roche at $74.00 per share is unfair to NASDAQ:ITMN stockholders.
View full press release